Agribiotech Monsanto (NYSE: MON )
is always going to be a lightning rod for criticism and scrutiny --
well, more so than other seed trait and chemical companies like DuPont (NYSE: DD ) , Syngenta (NYSE: SYT ) , and Dow Chemical (NYSE: DOW )
. Even so, the company's significant sustained yield advantages and its
deep, expanding pipeline make it a company and a stock well worth
watching. Should the company's more recent efforts in RNA interference,
integrated farming planning/management, and biologicals pay off, there
could appealing upside to today's price.
Please continue here:
Monsanto Company's Pipeline Is The Real Draw Today
No comments:
Post a Comment